SG Americas Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $399K | Buy |
113,630
+55,883
| +97% | +$229K | ﹤0.01% | 2310 |
|
|
2025
Q4 | $195K | Buy |
57,747
+20,795
| +56% | +$54K | ﹤0.01% | 2937 |
|
|
2025
Q3 | $48K | Buy |
+36,952
| New | +$38.2K | ﹤0.01% | 3206 |
|
|
2025
Q2 | – | Sell |
-27,118
| Closed | -$40K | – | 3260 |
|
|
2025
Q1 | $40K | Buy |
27,118
+15,249
| +128% | +$36.3K | ﹤0.01% | 3290 |
|
|
2024
Q4 | $53K | Buy |
+11,869
| New | +$48.2K | ﹤0.01% | 2897 |
|
|
2024
Q3 | – | Sell |
-18,769
| Closed | -$122K | – | 3512 |
|
|
2024
Q2 | $122K | Buy |
18,769
+8,277
| +79% | +$58.5K | ﹤0.01% | 2434 |
|
|
2024
Q1 | $91K | Buy |
+10,492
| New | +$127K | ﹤0.01% | 2590 |
|
|
2023
Q4 | – | Sell |
-188,807
| Closed | -$1.82M | – | 3263 |
|
|
2023
Q3 | $1.82M | Buy |
+188,807
| New | +$1.85M | 0.02% | 806 |
|
|
2023
Q2 | – | Sell |
-312,990
| Closed | -$3.29M | – | 2714 |
|
|
2023
Q1 | $3.29M | Buy |
312,990
+303,040
| +3,046% | +$3.39M | 0.04% | 429 |
|
|
2022
Q4 | $123K | Buy |
+9,950
| New | +$113K | ﹤0.01% | 2572 |
|
|
2022
Q3 | – | Sell |
-44,888
| Closed | -$518K | – | 3363 |
|
|
2022
Q2 | $518K | Sell |
44,888
-249,801
| -85% | -$2.94M | 0.01% | 1928 |
|
|
2022
Q1 | $3.71M | Buy |
+294,689
| New | +$3.38M | 0.03% | 563 |
|
|
2021
Q4 | – | Sell |
-16,458
| Closed | -$215K | – | 3592 |
|
|
2021
Q3 | $215K | Buy |
+16,458
| New | +$213K | ﹤0.01% | 3185 |
|
|
2021
Q2 | – | Sell |
-15,531
| Closed | -$174K | – | 3040 |
|
|
2021
Q1 | $174K | Buy |
+15,531
| New | +$164K | ﹤0.01% | 2765 |
|
|
2020
Q4 | – | Sell |
-161,481
| Closed | -$1.45M | – | 3402 |
|
|
2020
Q3 | $1.45M | Sell |
161,481
-14,331
| -8% | -$142K | 0.01% | 976 |
|
|
2020
Q2 | $1.81M | Buy |
175,812
+135,779
| +339% | +$1.39M | 0.02% | 895 |
|
|
2020
Q1 | $404K | Buy |
40,033
+31,506
| +369% | +$370K | ﹤0.01% | 2013 |
|
|
2019
Q4 | $113K | Sell |
8,527
-8,621
| -50% | -$95.1K | ﹤0.01% | 2883 |
|
|
2019
Q3 | $147K | Sell |
17,148
-4,491
| -21% | -$43.6K | ﹤0.01% | 2519 |
|
|
2019
Q2 | $237K | Buy |
21,639
+12,664
| +141% | +$142K | ﹤0.01% | 2322 |
|
|
2019
Q1 | $102K | Buy |
+8,975
| New | +$100K | ﹤0.01% | 3061 |
|
|
2018
Q4 | – | Sell |
-122,430
| Closed | -$1.89M | – | 3183 |
|
|
2018
Q3 | $1.89M | Buy |
122,430
+85,642
| +233% | +$1.35M | 0.01% | 1218 |
|
|
2018
Q2 | $589K | Buy |
36,788
+26,109
| +244% | +$386K | 0.01% | 1885 |
|
|
2018
Q1 | $138K | Buy |
+10,679
| New | +$133K | ﹤0.01% | 2702 |
|
|
2017
Q4 | – | Sell |
-33,655
| Closed | -$445K | – | 3415 |
|
|
2017
Q3 | $445K | Buy |
33,655
+18,513
| +122% | +$255K | ﹤0.01% | 1935 |
|
|
2017
Q2 | $239K | Sell |
15,142
-4,516
| -23% | -$65.6K | ﹤0.01% | 2297 |
|
|
2017
Q1 | $281K | Sell |
19,658
-71,831
| -79% | -$982K | ﹤0.01% | 2210 |
|
|
2016
Q4 | $1.17M | Buy |
91,489
+81,941
| +858% | +$1.03M | 0.01% | 1206 |
|
|
2016
Q3 | $127K | Buy |
+9,548
| New | +$112K | ﹤0.01% | 2867 |
|
|
2015
Q3 | – | Sell |
-10,026
| Closed | -$101K | – | 2388 |
|
|
2015
Q2 | $101K | Sell |
10,026
-10,381
| -51% | -$121K | ﹤0.01% | 2363 |
|
|
2015
Q1 | $273K | Sell |
20,407
-6,712
| -25% | -$88.1K | ﹤0.01% | 1731 |
|
|
2014
Q4 | $348K | Buy |
27,119
+17,616
| +185% | +$202K | ﹤0.01% | 1927 |
|
|
2014
Q3 | $103K | Sell |
9,503
-48,269
| -84% | -$553K | ﹤0.01% | 2361 |
|
|
2014
Q2 | $742K | Buy |
57,772
+10,740
| +23% | +$117K | ﹤0.01% | 1496 |
|
|
2014
Q1 | $485K | Buy |
+47,032
| New | +$529K | ﹤0.01% | 1485 |
|
|
2013
Q4 | – | Sell |
-21,066
| Closed | -$209K | – | 2819 |
|
|
2013
Q3 | $209K | Buy |
21,066
+7,303
| +53% | +$71.6K | ﹤0.01% | 2152 |
|
|
2013
Q2 | $115K | Buy |
+13,763
| New | +$167K | ﹤0.01% | 2030 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
SG Americas Securities's IRWD Position: Q1 2026 in Review
SG Americas Securities increased its Ironwood Pharmaceuticals (IRWD) stake by 97% in Q1 2026, buying an estimated $229K and bringing the position to 113,630 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #2310.
SG Americas Securities first reported a position in IRWD in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.71M in Q1 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- SG Americas Securities held 113,630 shares of Ironwood Pharmaceuticals worth $399K as of Q1 2026.
- SG Americas Securities bought 55,883 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $229K.
- Ironwood Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2310 holding.
- SG Americas Securities first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
- SG Americas Securities's Ironwood Pharmaceuticals position peaked at $3.71M in Q1 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.